CD8+ TM cell yield, purity, and infusion dose after tandem selection
Dose level . | Cell count, × 109 . | Recovery of CD8+CD45RA– cells after tandem selection, % . | CD8+CD45RA– cells in infused product, % . | Infused product cell count, × 106 per kg . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Before CD8+ CD45RA– selection . | After CD45RA reduction . | After CD8 enrichment . | ||||||||||
Mean . | Range . | Mean . | Range . | Mean . | Range . | Mean . | Range . | Mean . | Range . | Mean . | Range . | |
1 | 1.3 | 0.9-1.6 | 0.7 | 0.6-0.9 | 0.4 | 0.2-0.9 | 30.7 | 12.5-54.1 | 85.7 | 80.1-96.8 | 1.0 | 1.0-1.0 |
2 | 3.3 | 2.4-4.3 | 3.0 | 1.2-4.6 | 1.18 | 0.5-1.9 | 38.8 | 34.6-44.3 | 97.5 | 96.4-99.7 | 5.0 | 5.0-5.0 |
3 | 3.3 | 0.9-7.8 | 2.8 | 0.9-6.9 | 1.2 | 0.4-3.1 | 39.6 | 27.7-61.5 | 93.1 | 80.5-98.6 | 8.7 | 5.2-10.0 |
Dose level . | Cell count, × 109 . | Recovery of CD8+CD45RA– cells after tandem selection, % . | CD8+CD45RA– cells in infused product, % . | Infused product cell count, × 106 per kg . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Before CD8+ CD45RA– selection . | After CD45RA reduction . | After CD8 enrichment . | ||||||||||
Mean . | Range . | Mean . | Range . | Mean . | Range . | Mean . | Range . | Mean . | Range . | Mean . | Range . | |
1 | 1.3 | 0.9-1.6 | 0.7 | 0.6-0.9 | 0.4 | 0.2-0.9 | 30.7 | 12.5-54.1 | 85.7 | 80.1-96.8 | 1.0 | 1.0-1.0 |
2 | 3.3 | 2.4-4.3 | 3.0 | 1.2-4.6 | 1.18 | 0.5-1.9 | 38.8 | 34.6-44.3 | 97.5 | 96.4-99.7 | 5.0 | 5.0-5.0 |
3 | 3.3 | 0.9-7.8 | 2.8 | 0.9-6.9 | 1.2 | 0.4-3.1 | 39.6 | 27.7-61.5 | 93.1 | 80.5-98.6 | 8.7 | 5.2-10.0 |